Mark S Leventhal, a director of ProPhase Labs, recently acquired 35,752 shares of the company. The buys took place at $1.30 per share, on dates ranging from November 24 to November 25, 2015. Leventhal now owns 867,732 shares of the company. Leventhal operates out of Doylestown, PA. Some additional info was provided as follows:
This amended filing is being made to change the transaction code from the original "A" designation to a "P" designation to align with the description of the transactions disclosed in the original Form 4 filings as filed on November 25, 2015.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.34, inclusive.
The price reported in Column 4 is a weighte
d average price. These shares were purchased in multiple transactions at prices ranging from $1.27 to $1.33, inclusive.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!
Other recent filings from the company include the following:
ProPhase Labs's Chief Accounting Officer just declared owning 7,428 shares of ProPhase Labs - Jan. 23, 2018
Major owner of ProPhase Labs just disposed of 424,789 shares - Dec. 26, 2017
General statement of acquisition of beneficial ownership - Dec. 26, 2017